The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism?

An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs

Kozak, M. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.20.8125 · Cited by 5,090 · see citing works

Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes

Kozak, M. (1986) · Cell · doi:10.1016/0092-8674(86)90762-2 · Cited by 4,741 · see citing works

Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies

Hokanson, J. E., & Austin, M. A. (1996) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199604000-00014 · Cited by 1,706 · see citing works

Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes

Lewis, G. F., Carpentier, A. C., Adeli, K., & Giacca, A. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0461 · Cited by 1,328 · see citing works

PPARalpha and PPARgamma activators direct a distinct tissue‐specific transcriptional response via a PPRE in the lipoprotein lipase gene.

Schoonjans, K., Peinado‐Onsurbe, J., Lefebvre, A. M., Heyman, R. A., Briggs, M., Deeb, S., Staels, B., & Auwerx, J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00918.x · Cited by 1,173 · see citing works

An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative Sequencing

Pennacchio, L. A., Olivier, M., Hubacek, J. A., Cohen, J. C., Cox, D. R., Fruchart, J.-C., Krauss, R. M., & Rubin, E. M. (2001) · Science · doi:10.1126/science.1064852 · Cited by 921 · see citing works

The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function.

Segrest, J., Jones, M., Loof, H. D., Brouillette, C. G., Venkatachalapathi, Y. V., & Anantharamaiah, G. M. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41536-6 · Cited by 868 · see citing works

A Neural Network Method for Identification of Prokaryotic and Eukaryotic Signal Peptides and Prediction of their Cleavage Sites

Nielsen, H., Engelbrecht, J., Brunak, S., & von HEIJNE, G. (1997) · International Journal of Neural Systems · doi:10.1142/s0129065797000537 · Cited by 695 · see citing works

Triglyceride Concentration and Ischemic Heart Disease

Jeppesen, J., Hein, H. O., Suadicani, P., & Gyntelberg, F. (1998) · Circulation · doi:10.1161/01.cir.97.11.1029 · Cited by 673 · see citing works

Hypertriglyceridemia as a Result of Human apo <i>CII</i> Gene Expression in Transgenic Mice

Ito, Y., Azrolan, N., O'Connell, A., Walsh, A., & Breslow, J. L. (1990) · Science · doi:10.1126/science.2167514 · Cited by 539 · see citing works

Recognition of AUG and alternative initiator codons is augmented by G in position +4 but is not generally affected by the nucleotides in positions +5 and +6

Kozak, M. (1997) · The EMBO Journal · doi:10.1093/emboj/16.9.2482 · Cited by 478 · see citing works

The Metabolic Syndrome

Reilly, M. P., & Rader, D. J. (2003) · Circulation · doi:10.1161/01.cir.0000088846.10655.e0 · Cited by 466 · see citing works

Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles.

Aalto‐Setälä, K., Fisher, E. A. A., Chen, X., Chajek‐Shaul, T., Hayek, T., Zechner, R., Walsh, A., Ramakrishnan, R., Ginsberg, H. N., & Breslow, J. L. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116066 · Cited by 450 · see citing works

Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI: evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo

Ginsberg, H. N., Le, N. A., Goldberg, I. J., Gibson, J. C., Rubinstein, A., Wang-Iverson, P., Norum, R., & Brown, W. V. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112713 · Cited by 424 · see citing works

Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III.

Wang, C. S., McConathy, W. J., Kloer, H. U., & Alaupovic, P. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111711 · Cited by 414 · see citing works

Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates.

Staels, B., Vu-Dac, N., Kosykh, V. A., Saladin, R., Fruchart, J. C., Dallongeville, J., & Auwerx, J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117717 · Cited by 410 · see citing works

Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels

Pennacchio, L. A. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.24.3031 · Cited by 381 · see citing works

Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides

Talmud, P. J. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.24.3039 · Cited by 365 · see citing works

Apolipoprotein A-V

van der Vliet, H. N., Groenink, M., Leegwater, A. C. J., Levels, J. H. M., Reitsma, P. H., BOERS, W., & Chamuleau, R. A. F. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106888200 · Cited by 344 · see citing works

Mode of Action of Peroxisome Proliferators as Hypolipidemic Drugs.

Hertz, R., Bishara-Shieban, J., & Bar‐Tana, J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.13470 · Cited by 339 · see citing works

Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver.

Windler, E. E. T., & Havel, R. J. (1985) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34342-x · Cited by 314 · see citing works

Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia.

Maeda, N., Li, H., Lee, D., Oliver, P. M., Quarfordt, S. H., & Osada, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31559-4 · Cited by 313 · see citing works

Coronary Restenosis After Sirolimus-Eluting Stent Implantation

Lemos, P. A., Saia, F., Ligthart, J. M. R., et al. (2003) · Circulation · doi:10.1161/01.cir.0000083366.33686.11 · Cited by 288 · see citing works

Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway.

Sehayek, E., & Eisenberg, S. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55263-7 · Cited by 283 · see citing works

Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia.

Li, W. W., Dammerman, M. M., Smith, J. D., Metzger, S., Breslow, J. L., & Leff, T. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118324 · Cited by 278 · see citing works

Overexpression of human apolipoprotein C-III in transgenic mice results in an accumulation of apolipoprotein B48 remnants that is corrected by excess apolipoprotein E.

de Silva, H. V., Lauer, S. J., Wang, J., Simonet, W. S., Weisgraber, K. H., Mahley, R. W., & Taylor, J. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42171-5 · Cited by 209 · see citing works

Apolipoprotein A5, a Crucial Determinant of Plasma Triglyceride Levels, Is Highly Responsive to Peroxisome Proliferator-activated Receptor α Activators

Vu‐Dac, N., Gervois, P. P., Jäkel, H., Nowak, M., Baugé, E., Dehondt, H., Staels, B., Pennacchio, L. A., Rubin, E. M., Fruchart‐Najib, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212191200 · Cited by 206 · see citing works

The Human Apolipoprotein AV Gene Is Regulated by Peroxisome Proliferator-activated Receptor-α and Contains a Novel Farnesoid X-activated Receptor Response Element

Prieur, X., Coste, H., & Rodríguez, J. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301302200 · Cited by 194 · see citing works

Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E.

Ebara, T., Ramakrishnan, R., Steiner, G. A., & Shachter, N. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119456 · Cited by 191 · see citing works

Identification of Rev-erbα as a physiological repressor of apoC-III gene transcription

Raspé, E., Duez, H., Mansén, A., Fontaine, C., Fiévet, C., Fruchart, J.-C., Vennström, B., & Staels, B. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200386-jlr200 · Cited by 183 · see citing works

Inhibition of lipoprotein lipase activity by synthetic peptides of apolipoprotein C-III.

Wj, M., Gesquière, J. C., Bass, H. B., Tartar, A. L., Fruchart, J., & Wang, C. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41415-4 · Cited by 173 · see citing works

A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia

Kao, J. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg255 · Cited by 170 · see citing works

Adenoviral overexpression of apolipoprotein A-V reduces serum levels of triglycerides and cholesterol in mice

van der Vliet, H. N., Schaap, F. G., Levels, J. H. M., Ottenhoff, R., Looije, N., Wesseling, J. G., Groen, A. K., & Chamuleau, R. A. F. M. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00808-2 · Cited by 168 · see citing works

Apolipoprotein A5 , a Newly Identified Gene That Affects Plasma Triglyceride Levels in Humans and Mice

Pennacchio, L. A., & Rubin, E. M. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000054194.78240.45 · Cited by 168 · see citing works

The apoAI-CIII-AIV gene cluster

Groenendijk, M. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00539-1 · Cited by 166 · see citing works

Structure and Interfacial Properties of Human Apolipoprotein A-V

Weinberg, R. B., Cook, V. R., Beckstead, J. A., Martin, D. D. O., Gallagher, J. W., Shelness, G. S., & Ryan, R. O. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303784200 · Cited by 155 · see citing works

Contribution of Fatty Acids Released From Lipolysis of Plasma Triglycerides to Total Plasma Fatty Acid Flux and Tissue-Specific Fatty Acid Uptake

Teusink, B., Voshol, P. J., Dahlmans, V. E. H., Rensen, P. C. N., Pijl, H., Romijn, J. A., & Havekes, L. M. (2003) · Diabetes · doi:10.2337/diabetes.52.3.614 · Cited by 153 · see citing works

Fibrates Increase Human REV-ERBα Expression in Liver via a Novel Peroxisome Proliferator-Activated Receptor Response Element

Gervois, P. P., Delannoy, S., Fadel, A., Dubois, G., Kosykh, V., Fruchart, J., Najïb, J., Laudet, V., & Staels, B. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.3.0248 · Cited by 144 · see citing works

Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease

Olivieri, O., Bassi, A., Stranieri, C., Trabetti, E., Martinelli, N., Pizzolo, F., Girelli, D., Friso, S., Pignatti, P. F., & Corrocher, R. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300253-jlr200 · Cited by 139 · see citing works

Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice

Jong, M. C., Rensen, P. C. N., Dahlmans, V. E. H., van der Boom, H., van Berkel, T. J. C., & Havekes, L. M. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32211-2 · Cited by 136 · see citing works

The genetic effect of the apoprotein AV gene on the serum triglyceride level in Japanese

Nabika, T., Nasreen, S., Kobayashi, S., & Masuda, J. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00252-6 · Cited by 135 · see citing works

Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders

Onat, A., Hergenç, G., Sansoy, V., Fobker, M., Ceyhan, K., Toprak, S., & Assmann, G. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00025-x · Cited by 134 · see citing works

Transcriptional Regulation of Apolipoprotein C-III Gene Expression by the Orphan Nuclear Receptor RORα

Raspé, E., Duez, H., Gervois, P., Fiévet, C., Fruchart, J., Besnard, S., Mariani, J., Tedgui, A., & Staels, B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004982200 · Cited by 134 · see citing works

Protection From Obesity in Mice Lacking the VLDL Receptor

Goudriaan, J. R., Tacken, P. J., Dahlmans, V. E. H., Gijbels, M. J. J., van Dijk, K. W., Havekes, L. M., & Jong, M. C. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0901.095147 · Cited by 133 · see citing works

The effect of human C apolipoproteins on the in vitro hepatic metabolism of triglyceride emulsions in the rat.

Quarfordt, S. H., Michalopoulos, G. K., & Schirmer, B. D. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33329-5 · Cited by 132 · see citing works

Contribution of APOA5 gene variants to plasma triglyceride determination and to the response to both fat and glucose tolerance challenges

Martin, S., Nicaud, V., Humphries, S. E., & Talmud, P. J. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(03)00033-4 · Cited by 119 · see citing works

Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids

Aouizerat, B. E., Kulkarni, M. V., Heilbron, D. C., Drown, D. J., Raskin, S., Pullinger, C. R., Malloy, M. J., & Kane, J. P. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200480-jlr200 · Cited by 118 · see citing works

Linkage and Association Between Distinct Variants of the APOA1/C3/A4/A5 Gene Cluster and Familial Combined Hyperlipidemia

Eichenbaum‐Voline, S., Olivier, M., Jones, E. L., Naoumova, R. P., Jones, B., Gau, B. C., Patel, H., Seed, M., Betteridge, D. J., Galton, D. J., et al. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000099881.83261.d4 · Cited by 105 · see citing works

Protection From Obesity and Insulin Resistance in Mice Overexpressing Human Apolipoprotein C1

Jong, M. C., Voshol, P. J., Muurling, M., Dahlmans, V. E. H., Romijn, J. A., Pijl, H., & Havekes, L. M. (2001) · Diabetes · doi:10.2337/diabetes.50.12.2779 · Cited by 97 · see citing works

The single nucleotide polymorphism ?1131T>C in the apolipoprotein A5 (APOA5) gene is associated with elevated triglycerides in patients with hyperlipidemia

Evans, D. G., Buchwald, A., & Beil, F. U. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0465-4 · Cited by 93 · see citing works

Transcriptional regulatory mechanisms of the human apolipoprotein genes in vitro and in vivo

Zannis, V. I., Kan, H.-Y., Κritis, A., Zanni, E. E., & Kardassis, D. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200104000-00012 · Cited by 88 · see citing works

ApoCIII Gene Variants Modulate Postprandial Response to Both Glucose and Fat Tolerance Tests

Waterworth, D. M., Ribalta, J., Nicaud, V., Dallongeville, J., Humphries, S. E., & Talmud, P. J. (1999) · Circulation · doi:10.1161/01.cir.99.14.1872 · Cited by 85 · see citing works

APOA5‐1131T>C polymorphism is associated with triglyceride levels in Chinese men

Baum, L., Tomlinson, B., & Thomas, G. N. (2003) · Clinical Genetics · doi:10.1034/j.1399-0004.2003.00063.x · Cited by 85 · see citing works

Orphan Nuclear Hormone Receptor Rev-erbα Regulates the Human Apolipoprotein CIII Promoter

Coste, H., & Rodríguez, J. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203421200 · Cited by 83 · see citing works

Apolipoprotein C-III(Lys58----Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemia.

von Eckardstein, A., Holz, H., Sandkamp, M., Weng, W., Funke, H., & Assmann, G. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115190 · Cited by 81 · see citing works

Structure−Function Studies of Human Apolipoprotein A-V: A Regulator of Plasma Lipid Homeostasis

Beckstead, J. A., Oda, M. N., Martin, D. D. O., Forte, T. M., Bielicki, J. K., Berger, T., Luty, R., Kay, C. M., & Ryan, R. O. (2003) · Biochemistry · doi:10.1021/bi034509t · Cited by 76 · see citing works

Hypertriglyceridemia: new insights and new approaches to pharmacologic therapy

Ginsberg, H. N. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01489-8 · Cited by 60 · see citing works

T-1131→C polymorphism within the apolipoprotein AV gene in hypertriglyceridemic individuals

Hořínek, A. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00022-4 · Cited by 55 · see citing works

Lipid binding by fragments of apolipoprotein C-III-1 obtained by thrombin cleavage

Sparrow, J. T., Pownall, H. J., Hsu, F. J., Blumenthal, L. D., Culwell, A. R., & Gotto, A. M. (1977) · Biochemistry · doi:10.1021/bi00644a004 · Cited by 52 · see citing works

Molecular cloning of a human apoC-III variant: Thr 74----Ala 74 mutation prevents O-glycosylation.

Maeda, H., Hashimoto, R. K., Ogura, T., Hiraga, S., & UZAWA, H. (1987) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38574-6 · Cited by 47 · see citing works

Characterization of Recombinant Wild Type and Site-Directed Mutations of Apolipoprotein C-III: Lipid Binding, Displacement of ApoE, and Inhibition of Lipoprotein Lipase

Liu, H., Talmud, P. J., Lins, L., Brasseur, R., Olivecrona, G., Peelman, F., Vandekerckhove, J. S., Rosseneu, M., & Labeur, C. (2000) · Biochemistry · doi:10.1021/bi0009441 · Cited by 42 · see citing works

Lipid-interacting properties of the N-terminal domain of human apolipoprotein C-III

Lins, L., Flore, C., Chapelle, L., Talmud, P. J., Thomas, A., & Brasseur, R. (2002) · Protein Engineering Design and Selection · doi:10.1093/protein/15.6.513 · Cited by 42 · see citing works

Characterization of the lipid-binding properties and lipoprotein lipase inhibition of a novel apolipoprotein C-III variant Ala23Thr

Liu, H., Labeur, C., Xu, C., Ferrell, R. E., Lins, L., Brasseur, R., Rosseneu, M., Weiss, K. M., Humphries, S. E., & Talmud, P. J. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31969-6 · Cited by 41 · see citing works

Mutagenesis of the glycosylation site of human ApoCIII. O-linked glycosylation is not required for ApoCIII secretion and lipid binding.

Roghani, A., & Zannis, V. I. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)81305-4 · Cited by 39 · see citing works

The Apolipoprotein AV Gene and Diurnal Triglyceridaemia in Normolipidaemic Subjects

Masana, L., Ribalta, J., Salazar, J., Fernandez-Ballart, J. D., Joven, J., & Cabezas, M. C. (2003) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2003.078 · Cited by 39 · see citing works

Variants in the APOC3 promoter insulin responsive element modulate insulin secretion and lipids in middle-aged men

Waterworth, D. M., Talmud, P. J., Luan, J., Flavell, D. M., Byrne, C. D., Humphries, S. E., & Wareham, N. J. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(03)00021-8 · Cited by 37 · see citing works

Electrophoretic screening for genetic variation in apolipoprotein C-III: identification of a novel apoC-III variant, apoC-III(Asp45–>Asn), in a Turkish patient.

Lüttmann, S., von Eckardstein, A., Wei, W., Funke, H., Köhler, E., Mahley, R. W., & Assmann, G. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40084-7 · Cited by 35 · see citing works

A novel apolipoprotein C-III variant, apoC-III(Gln38–>Lys), associated with moderate hypertriglyceridemia in a large kindred of Mexican origin

Pullinger, C. R., Malloy, M. J., Shahidi, A. K., Ghassemzadeh, M., Duchateau, P. N., Villagomez, J., Allaart, J., & Kane, J. P. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37157-1 · Cited by 26 · see citing works

Apoprotein C-III deficiency markedly stimulates triglyceride secretion in vivo: comparison with apoprotein E

Hirano, T., Takahashi, T., Saito, S., Tajima, H., Ebara, T., & Adachi, M. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.4.e665 · Cited by 23 · see citing works

Effect of the apolipoprotein C-IIC-III1 ratio on the capacity of purified milk lipoprotein lipase to hydrolyse triglycerides in monolayer vesicles

Lambert, D. A., Catapano, A. L., Smith, L. C., et al. (1996) · Atherosclerosis · doi:10.1016/s0021-9150(96)05955-2 · Cited by 17 · see citing works

Effect of apoC-III gene polymorphisms on the lipoprotein-lipid profile of viscerally obese men Published, JLR Papers in Press, February 16, 2003. DOI 10.1194/jlr.M300043-JLR200

Couillard, C., Vohl, M., Engert, J., Lemieux, I., Houde, A., Alméras, N., Prud'homme, D., Nadeau, A., Despres, J., & Bergeron, J. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300043-jlr200 · Cited by 11 · see citing works

Lipids and Lipid-Based Formulations: Optimizing the Oral Delivery of Lipophilic Drugs

Porter, C. J. H., Trevaskis, N. L., & Charman, W. N. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2197 · Cited by 1,824 · see citing works

Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease

Petersen, K. F., Dufour, S., Hariri, A., Nelson-Williams, C., Foo, J. N., Zhang, X.-M., Dziura, J., Lifton, R. P., & Shulman, G. I. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907295 · Cited by 428 · see citing works

The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans

Borén, J., Packard, C. J., & Taskinen, M.-R. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00474 · Cited by 196 · see citing works

Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics.

Chan, D. C., Watts, G. F., Nguyen, M. N., & Barrett, P. H. R. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000203519.25116.54 · Cited by 70 · see citing works

Serum Levels of ApoA1 and ApoA2 Are Associated with Cognitive Status in Older Men

Ma, C., Li, J., Bao, Z., Ruan, Q., & Yu, Z. (2015) · BioMed Research International · doi:10.1155/2015/481621 · Cited by 46 · see citing works

Correlation Among Triglyceride and Coagulative and Fibrinolytic Parameters in Patients with Coronary Heart Disease

Huang, Q. (2006) · Journal of clinical research

The Effect of High-Carbohydrate Diets on Liver Triglyceride Formation in the Rat

Waddell, M., & Fallon, H. J. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107467 · Cited by 72 · see citing works

Correlation between triglyceride and plasma factor VIIc clouting in patients with coronary heart disease

De-qian, J. (2003) · Journal of Clinical Cardiology

A study measuring the effect of high serum triglyceride and cholesterol on glucose elevation in human serum.

Daboul, M. (2011) · Oman Medical Journal · doi:10.5001/omj.2011.27 · Cited by 14 · see citing works

Triglyceride accumulation in cultured human fibroblasts

Howard, B. V., Howard, W. J., Llera, M. D. L., et al. (1976) · Atherosclerosis · doi:10.1016/0021-9150(76)90012-5 · Cited by 22 · see citing works